MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

The prognosis of newly diagnosed patients with acute myeloid leukemia is still unfavorable in the majority of cases within the intermediate and mainly adverse genetic risk group but also in a considerable fraction of favorable-risk patients, mainly due to recurrence of disease after complete remissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardi, Massimo, Ferrara, Felicetto, Carrabba, Matteo Giovanni, Mastaglio, Sara, Lorentino, Francesca, Vago, Luca, Ciceri, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339596/
https://www.ncbi.nlm.nih.gov/pubmed/35924144
http://dx.doi.org/10.3389/fonc.2022.890871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339596/
https://www.ncbi.nlm.nih.gov/pubmed/35924144
http://dx.doi.org/10.3389/fonc.2022.890871

Ejemplares similares